Vitro Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vitro Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2022 to Q4 2024.
  • Vitro Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending January 31, 2025 was $315K, a 28.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $315K -$127K -28.8% Jan 31, 2025 10-Q 2025-03-20
Q3 2024 $346K -$130K -27.3% Oct 31, 2024 10-Q 2025-03-20
Q2 2024 $378K +$106K +39.2% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $410K +$158K +62.9% Apr 30, 2024 10-Q 2024-05-31
Q4 2023 $443K +$178K +67.4% Jan 31, 2024 10-Q 2024-03-14
Q3 2023 $476K +$199K +71.7% Oct 31, 2023 10-K 2025-01-28
Q2 2023 $271K May 31, 2023 10-Q 2025-03-20
Q1 2023 $252K Apr 30, 2023 10-Q 2023-06-13
Q4 2022 $264K Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $277K Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.